| Literature DB >> 33619096 |
James London1, Juana Martín-López1, Inho Yang2, Jiaquan Liu1, Jong-Bong Lee3,4, Richard Fishel5.
Abstract
The pathogenic consequences of 369 unique human HsMLH1 missense variants has been hampered by the lack of a detailed function in mismatch repair (MMR). Here single-molecule images show that HsMSH2-HsMSH6 provides a platform for HsMLH1-HsPMS2 to form a stable sliding clamp on mismatched DNA. The mechanics of sliding clamp progression solves a significant operational puzzle in MMR and provides explicit predictions for the distribution of clinically relevant HsMLH1 missense mutations.Entities:
Keywords: HNPCC; Lynch syndrome; mismatch repair; single molecule; sliding clamp
Mesh:
Substances:
Year: 2021 PMID: 33619096 PMCID: PMC7936337 DOI: 10.1073/pnas.2019215118
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205
Fig. 1.Real-time imaging of HsMSH2-HsMSH6 and HsMLH1-HsPMS2 on mismatched DNA. (A) Representative kymographs of a stable ATP-bound HsMLH1-Cy3HsPMS2 (2 nM) sliding clamp on an 18-kb mismatched DNA (see ref. 13). HsMLH1-Cy3HsPMS2 particles were visualized by smTIRF in the presence (Top) or absence (Bottom) of unlabeled HsMSH2-HsMSH6 (8 nM). Helix (Right) approximates the 18-kb mismatch DNA limits on which the HsMLH1-Cy3HsPMS2 clamp is sliding. Time and length reference bars are shown (left corner; 1 μm ∼3,900 bp; see ref. 13). (B) The frequency of HsMLH1-Cy3HsPMS2 sliding clamps on mismatched DNA in the presence (nDNA = 596) and absence (nDNA = 421) of HsMSH2-HsMSH6 (8 nM; mean ± SEM). (C) An illustration of the thermal wrapping mechanism for the formation of an HsMLH1-HsPMS2 sliding clamp. Mismatch recognition by HsMSH2-HsMSH6 provokes ATP binding and the formation of a sliding clamp (blue) that randomly diffuses along the DNA. The HsMSH2-HsMSH6 sliding clamps provides a platform for binding a single N-terminal domain of HsMLH1-HsPMS2, which permits wrapping of the unbound peptide domains around the DNA followed by dimerization and a distinctly different ATP binding process by the N-terminal HsMLH1 and HsPMS2 domains. (D) Position histogram of HsMSH2-Cy5HsMSH6 (50 nM) on a 48.5-kb SkyBridge DNA (see ref. 16) relative to Alexa488-marked mismatch (nDNA = 42). (Inset) Representative DNA SkyBridge molecule showing multiple HsMSH2-Cy5HsMSH6 particles (red) relative to Alexa488-localized mismatch (*, blue). Parallel SkyBridge platforms are marked (v) with mismatched DNA between (light gray). Single molecule positions (nDNA = 42) were established every 20 s for 100 s. (E) Blue histogram: location of HsMSH2-Cy5HsMSH6 (10 nM) in the presence of unlabeled HsMLH1-HsPMS2 (100 nM) on a 48.5-kb SkyBridge DNA (see ref. 16) relative to Alexa488-marked mismatch similar to C (nDNA = 51). Red histogram: location of colocalized HsMSH2-Cy5HsMSH6/HsMLH1-Cy3HsPMS2 (50 nM each) on a 48.5-kb SkyBridge DNA (see ref. 16) relative to Alexa488-marked mismatch similar to panel C (nDNA = 41). (Inset) Representative DNA SkyBridge molecule showing a colocalized HsMSH2-Cy5HsMSH6/HsMLH1-Cy3HsPMS2 (yellow), a solitary HsMLH1-Cy3HsPMS2 (green), and the Alexa488-marked mismatch (*, blue) (nDNA = 35). Parallel SkyBridge platforms are marked (v) with mismatched DNA between (light gray). Single molecules’ positions were established every 20 s for 100 s.
Fig. 2.The role of HsMLH1-HsPMS2 linker domains in cancer predisposition. (A) The N-terminal structures of HsMLH1 and HsPMS2 (Protein Data Bank [PDB] ID codes 4P7A and 1H7S) with the C-terminal dimerization structure of ScMlh1-ScPms1 (PDB ID code 4E4W) joined by human linker lengths. (B) The locations of N-terminal ATPase (green), linker (central black), and C-terminal dimerization (blue) domains of MutL homologs. (C) The number (N) and locations of unique HsMLH1 pathogenic (n = 71), nonpathogenic (n = 26), and uncertain (n = 369) MPVs, where 220 C-terminal (aa 3 to 336), 49 linker (aa 337 to 501), and 100 N-terminal (aa 502 to 756) unique MPVs were identified from 3,736 total MPVs.